Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma

Experimental and Molecular Pathology

Volumn 97, Issue 1, 2014, Pages 74-80

  Lv, Huixin ^a,b   Cui, Aili ^a   Sun, Fengdan ^b   Zhang, Yuan ^b   Li, Yan ^c   Li, Lianhua ^a   Lin, Zhenhua ^a,b  

^a YANBIAN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY MEDICAL COLLEGE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Prognosis; SIX1; Survival analysis

Indexed keywords

CARYOPHYLLENE; LIPOFUSCIN; TRANSCRIPTION FACTOR DAF 16;

ADULT; AGING; ANIMAL EXPERIMENT; ARTICLE; BODY SIZE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DAF 16 GENE; DRUG EFFECT; DRUG SCREENING; EAT 2 GENE; FEEDING BEHAVIOR; GENE; GENE EXPRESSION; LIFESPAN; LONGEVITY; MEV 1 GENE; MOLECULAR DOCKING; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PREDICTION; SIR 21 GENE; SKN 1 GENE; STRESS; TRANSGENICS; XENOBIOTIC METABOLISM;

GASTRIC CANCER; PROGNOSIS; SIX1; SURVIVAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; CELL LINE, TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901982712     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.05.007     Document Type: Article

References (34)

1. Ang T.L., et al. Diagnosis and endoscopic resection of early gastric cancer. Singapore Med. J. 2010, 51:93-100.
2. Behbakht K., et al. SIX1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res. 2007, 67:3036-3042.
3. Christensen K.L., et al. The SIX family of homeobox genes in development and cancer. Adv. Cancer Res. 2008, 101:93-126.
4. Coletta R.D., et al. SIX1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res. 2008, 68:2204-2213.
5. Elzagheid A., et al. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum. Pathol. 2008, 39(12):1737-1743.
6. Farabaugh S.M., et al. Eya2 is required to mediate the pro-metastatic functions of SIX1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 2012, 31(5):552-562.
7. Ferlay J., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127(12):2893-2917.
8. Ford H.L. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. PNAS ESI 1998, 95:12608-12613.
9. Fougerousse F., et al. Six and Eya expression during human somitogenesis and MyoD gene family activation. J. Muscle Res. Cell Motil. 2002, 23(3):255-264.
10. Greene F.L. AJCC Cancer Staging Manual Six Edition 2002, Springer Verlag, New York, NY, USA.
11. Guo C., et al. Tbx1-SIX1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis. J. Clin. Invest. 2011, 121(4):1585-1595.
12. Iwanaga R. Expression of SIX1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res. 2012, 14(4):R100.
13. Jin J., et al. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagn. Pathol. 2012, 7:135.
14. Jin A., et al. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Exp. Mol. Pathol. 2014, 96(1):54-60.
15. Li Z., et al. SIX1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One 2013, 8(3):e59203.
16. Lin L., et al. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer. BMC Cancer 2013, 13:366.
17. McCoy E.L., et al. SIX1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:2663-2677.
18. Micalizzi D.S., et al. The SIX1 homeoprotein includes human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-signaling. J. Clin. Invest. 2009, 119(9):2678-2690.
19. Mimae T., et al. Upregulation of Notch2 and SIX1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin. Cancer Res. 2012, 18:945-955.
20. Ng K.T., et al. Clinicopathological significance of homeoprotein SIX1 in hepatocellular carcinoma. Br. J. Cancer 2006, 95:1050-1055.
21. Ono H., et al. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 2012, 31(47):4923-4934.
22. Ozaki H., et al. SIX1 controls patterning of the mouse otic vesicle. Development 2004, 131(3):551-562.
23. Qamar L., et al. Specificity and prognostic validation of a polyclonal antibody to detect SIX1 homeoprotein in ovarian cancer. Gynecol. Oncol. 2012, 125(2):451-457.
24. Strizzi L., et al. Development and cancer: at the crossroads of nodal and notch signaling. Cancer Res. 2009, 69(18):7131-7134.
25. Tan J., et al. Expression and significance of SIX1 and ezrin in cervical cancer tissue. Tumour Biol. 2011, 32:1241-1247.
26. Wan F., et al. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int. J. Cancer 2008, 123:32-40.
27. Wang Q., et al. Pax genes in embryogenesis and oncogenesis. J. Cell. Mol. Med. 2008, 12(6A):2281-2294.
28. Wang C., et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J. Clin. Invest. 2012, 122(5):1895-1906.
29. Wang J., et al. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study. PLoS One 2013, 8(9):e73683.
30. Wei Q., et al. Expression of SIX1 and SIX4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis. Zhonghua Bing Li Xue Za Zhi 2013, 42(7):446-450.
31. Wöhrer S.S., et al. Palliative chemotherapy for advanced GAC. Ann. Oncol. 2004, 15:1585-1595.
32. Wu W., et al. Subcellular localization of different regions of porcine SIX1 gene and its expression analysis in C2C12 myoblasts. Mol. Biol. Rep. 2012, 39:9995-10002.
33. Yu Y., et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein SIX-1 as key metastatic regulators. Nat. Med. 2004, 10(2):175-181.
34. Yu Y., et al. The homeoprotein SIX1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res. 2006, 66(4):1982-1989. (15).